• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Surgical Removal Beneficial for Acute Intracerebral Hemorrhage

Medically reviewed by Carmen Pope, BPharm. Last updated on April 11, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, April 11, 2024 -- For patients with an acute intracerebral hemorrhage, minimally invasive surgical removal is associated with improved outcomes, according to a study published in the April 11 issue of the New England Journal of Medicine.

Gustavo Pradilla, M.D., from the Emory University School of Medicine in Atlanta, and colleagues randomly assigned patients with a lobar or anterior basal ganglia hemorrhage with a hematoma volume of 30 to 80 mL within 24 hours after the time they were last known to be well to minimally invasive surgical removal of the hematoma plus guideline-based medical management or guideline-based medical management alone in a 1:1 ratio. Three hundred patients were enrolled: 30.7 and 69.3 percent had anterior basal ganglia and lobal hemorrhages, respectively. An adaption rule was triggered after 175 patients had been enrolled and only persons with lobal hemorrhages were enrolled.

The researchers found that the mean score on the utility-weighted modified Rankin scale was 0.458 and 0.374 at 180 days in the surgery and control groups, respectively (posterior probability of superiority of surgery, 0.981). Among patients with lobar hemorrhages and patients with basal ganglia hemorrhages, the mean between-group difference was 0.127 and −0.013, respectively. The percentage of patients who had died by 30 days was 9.3 and 18.0 percent in the surgery and control groups, respectively. In the surgery group, five patients (3.3 percent) had postoperative rebleeding and neurological deterioration.

"Weighted disability scores were better with surgery plus medical management than with medical management alone," the authors write. "The result was apparently attributable to intervention for lobar supratentorial hemorrhages."

The study was funded by Nico.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted April 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.